|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets: | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Other current assets | ||||||
| Total Current Assets | ||||||
| Other assets | ||||||
| Investments held in the Trust Account | ||||||
| Total Assets | ||||||
| LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT | ||||||
| Current Liabilities: | ||||||
| Accounts payable and accrued expenses | ||||||
| Excise tax payable | ||||||
| Income taxes payable | ||||||
| Accrued offering costs | ||||||
| Convertible promissory | ||||||
| Total Current Liabilities | ||||||
| Deferred underwriting commission | ||||||
| Total Liabilities | ||||||
| Class A common stock subject to possible redemption; 9,294,308 and 28,750,000 at June 30, 2023 and December 31, 2022, respectively (at redemption value of $10.55 and $10.31 per share, respectively) | ||||||
| Common Class A | ||||||
| Total class A common stock subject to possible redemption; 9,294,308 and 28,750,000 at June 30, 2023 and December 31, 2022, respectively (at redemption value of $10.55 and $10.31 per share, respectively) | ||||||
| Stockholders' Deficit: | ||||||
| Common stock | ||||||
| Accumulated deficit | ||||||
| Total Stockholders' Deficit | ||||||
| Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit |
Loading...
